Serum fetuin A level is associated with nonalcoholic fatty liver disease in Chinese population

被引:12
作者
Cui, Zhengsen [1 ]
Xuan, Rong [2 ]
Yang, Yunmei [1 ]
机构
[1] Zhejiang Univ, Dept Geratol, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China
[2] Third Hosp Hangzhou, Dept Endocrine, Hangzhou 310000, Zhejiang, Peoples R China
来源
ONCOTARGET | 2017年 / 8卷 / 63期
关键词
fetuin A; non-alcoholic fatty liver disease; metabolic disorder; insulin resistance; serum biomarker; INSULIN-RESISTANCE; A LEVELS; METABOLIC SYNDROME; HEPATOKINES; STEATOSIS; DIAGNOSIS; CHILDREN; UPDATE; RISK;
D O I
10.18632/oncotarget.22361
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To investigate the association between serum fetuin A concentration and non-alcoholic fatty liver disease (NAFLD) in Chinese population. Methods: This case-control study enrolled 79 NAFLD cases and 79 non-NAFLD controls. All subjects were selected from Chinese population who received annual health examination in the First Affiliated Hospital of Zhejiang University in 2016. NAFLD was diagnosed mainly based on abdominal ultrasonography. The severity of NAFLD was categorized by serum level of alanine aminotransferase. Serum fetuin A was measured by ELISA. Results: Serum fetuin A level in NAFLD patients was significantly lower than that in controls (0.27 +/- 0.17 vs. 0.32 +/- 0.12g/L, P < 0.05). Compared with controls, mild NAFLD (0.24 +/- 0.16 g/L, P < 0.05) and moderate NAFLD (0.25 +/- 0.17 g/L, P < 0.05) had significantly lower concentration of Fetuin A, while Fetuin A level tended to slightly increase with the severity of NAFLD. The prevalence rate of NAFLD decreased (75 %, 40 %, and 36 %), as Fetuin A level elevated. ROC curve of Fetuin A was developed to predict the presence of NAFLD. Area under ROC was 0.656. Conclusion: Serum level of Fetuin A was lower in NAFLD patients than controls, while Fetuin A level increased with the severity of NAFLD, indicating a potential predicting role of Fetuin A in the development of NAFLD.
引用
收藏
页码:107149 / 107156
页数:8
相关论文
共 25 条
[1]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[2]   Relationship of Serum Fetuin-A Levels with Coronary Atherosclerotic Burden and NAFLD in Patients Undergoing Elective Coronary Angiography [J].
Ballestri, Stefano ;
Meschiari, Erica ;
Baldelli, Enrica ;
Musumeci, Francesca E. ;
Romagnoli, Dante ;
Trenti, Tommaso ;
Zennaro, Romeo G. ;
Lonardo, Amedeo ;
Loria, Paola .
METABOLIC SYNDROME AND RELATED DISORDERS, 2013, 11 (04) :289-295
[3]   Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: Update 2010 [J].
Fan, Jian Gao ;
Jia, Ji Dong ;
Li, You Ming ;
Wang, Bing Yuan ;
Lu, Lun Gen ;
Shi, Jun Pin ;
Chan, Lik Yuen .
JOURNAL OF DIGESTIVE DISEASES, 2011, 12 (01) :38-44
[4]   Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies [J].
Haukeland, John Willy ;
Dahl, Tuva B. ;
Yndestad, Arne ;
Gladhaug, Ivar P. ;
Loberg, Else Marit ;
Haaland, Terese ;
Konopski, Zbigniew ;
Wium, Cecilie ;
Aasheim, Erlend T. ;
Johansen, Odd Erik ;
Aukrust, Pal ;
Halvorsen, Bente ;
Birkeland, Kare I. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 166 (03) :503-510
[5]   Serum Fetuin-A is an Independent Marker of Insulin Resistance in Japanese Men [J].
Ishibashi, Ayako ;
Ikeda, Yukio ;
Ohguro, Takashi ;
Kumon, Yoshitaka ;
Yamanaka, Shigeo ;
Takata, Hiroshi ;
Inoue, Mari ;
Suehiro, Tadashi ;
Terada, Yoshio .
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2010, 17 (09) :925-933
[6]   Association between human fetuin-A and the metabolic syndrome - Data from the Heart and Soul Study [J].
Ix, JH ;
Shlipak, MG ;
Brandenburg, VM ;
Ali, S ;
Ketteler, M ;
Whooley, MA .
CIRCULATION, 2006, 113 (14) :1760-1767
[7]   Fetuin-A and incident diabetes mellitus in older persons [J].
Ix, Joachim H. ;
Wassel, Christina L. ;
Kanaya, Alka M. ;
Vittinghoff, Eric ;
Johnson, Karen C. ;
Koster, Annemarie ;
Cauley, Jane A. ;
Harris, Tamara B. ;
Cummings, Steven R. ;
Shlipak, Michael G. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (02) :182-188
[8]   Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A [J].
Jung, Tae Woo ;
Youn, Byung-Soo ;
Choi, Hae Yoon ;
Lee, So Young ;
Hong, Ho Cheol ;
Yang, Sae Jeong ;
Yoo, Hye Jin ;
Kim, Baek-Hui ;
Baik, Sei Hyun ;
Choi, Kyung Mook .
BIOCHEMICAL PHARMACOLOGY, 2013, 86 (07) :960-969
[9]   Hepatokines and non-alcoholic fatty liver disease [J].
Lebensztejn, Dariusz M. ;
Flisiak-Jackiewicz, Marta ;
Bialokoz-Kalinowska, Irena ;
Bobrus-Chociej, Anna ;
Kowalska, Irina .
ACTA BIOCHIMICA POLONICA, 2016, 63 (03) :459-467
[10]   Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease [J].
Lebensztejn, Dariusz M. ;
Bialokoz-Kalinowska, Irena ;
Klusek-Oksiuta, Monika ;
Tarasow, Eugeniusz ;
Wojtkowska, Malgorzata ;
Kaczmarski, Maciej .
ADVANCES IN MEDICAL SCIENCES, 2014, 59 (01) :81-84